NCT04791033

Quality of Life After Hysterectomy (AdenoQOL)

Quality of Life After Hysterectomy for Adenomyosis and Other Benign Gynecological Conditions

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 218 (estimated)
• Sponsor: Oslo University Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 52 Years
• Healthy volunteers: Not accepted

Summary

Adenomyosis is a disease where ectopic endometrial-like glands affect the muscular wall of the uterus. About 70% of women affected by adenomyosis suffer from dysmenorrhea and menorrhagia. A levonorgestrel-releasing intrauterine device (LNG-IUD) is the first-choice treatment of adenomyosis, but is not always sufficiently effective in all women. Those women often end up removing the uterus (hysterectomy). Hysterectomy is clinically regarded to be an efficient and final treatment of adenomyosis, but pelvic pain may also prevail after removal of the uterus. This study aimes to investigate the short - and long-term impact of hysterectomy on quality of life (QOL) and sexual function in women with adenomyosis, and further to evaluate if there is any difference compared to women that are removing their uterus due to other benign gynecological conditions.

Conditions

• Adenomyosis
• Quality of Life

Interventions

Type	Name	Description
PROCEDURE	Hysterectomy	Elective procedure with hysterectomy due to benign gynecological condition

Timeline

• Start date: 2021-03-18
• Primary completion: 2022-10-30
• Completion: 2030-12-01
• First posted: 2021-03-10
• Last updated: 2024-04-19

Locations

1 site across 1 country: Norway